HIF-2α regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth

  1. Kelly L. Covello1,
  2. James Kehler4,
  3. Hongwei Yu2,
  4. John D. Gordan2,
  5. Andrew M. Arsham2,5,
  6. Cheng-Jun Hu2,
  7. Patricia A. Labosky1,
  8. M. Celeste Simon1,2,3,6, and
  9. Brian Keith2
  1. 1Department of Cell and Developmental Biology, 2Abramson Family Cancer Research Institute, 3Howard Hughes Medical Institute, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA; 4Center for Animal Transgenesis and Germ Cell Research, New Bolton Center, University of Pennsylvania, Philadelphia, Pennsylvania 19348, USA

Abstract

The division, differentiation, and function of stem cells and multipotent progenitors are influenced by complex signals in the microenvironment, including oxygen availability. Using a genetic “knock-in” strategy, we demonstrate that targeted replacement of the oxygen-regulated transcription factor HIF-1α with HIF-2α results in expanded expression of HIF-2α-specific target genes including Oct-4, a transcription factor essential for maintaining stem cell pluripotency. We show that HIF-2α, but not HIF-1α, binds to the Oct-4 promoter and induces Oct-4 expression and transcriptional activity, thereby contributing to impaired development in homozygous Hif-2α KI/KI embryos, defective hematopoietic stem cell differentiation in embryoid bodies, and large embryonic stem cell (ES)-derived tumors characterized by altered cellular differentiation. Furthermore, loss of HIF-2α severely reduces the number of embryonic primordial germ cells, which require Oct-4 expression for survival and/or maintenance. These results identify Oct-4 as a HIF-2α-specific target gene and indicate that HIF-2α can regulate stem cell function and/or differentiation through activation of Oct-4, which in turn contributes to HIF-2α's tumor promoting activity.

Keywords

Footnotes

  • Supplemental material is available at http://www.genesdev.org.

  • Article and publication are at http://www.genesdev.org/cgi/doi/10.1101/gad.1399906.

  • 5 Present address: Department of Genetics, Cell Biology, and Development, University of Minnesota, Minneapolis, MN 55455, USA.

  • 6 Corresponding author. E-MAIL celeste2{at}mail.med.upenn.edu; FAX (215) 746-5511.

    • Accepted January 11, 2006.
    • Received December 8, 2005.
| Table of Contents

Life Science Alliance